Detection of Sentinel Lymph Nodes in patients with Early Stage Cervical Cancer.
10.3346/jkms.2007.22.1.105
- Author:
Seok Ju SEONG
1
;
Hyun PARK
;
Kwang Moon YANG
;
Tae Jin KIM
;
Kyung Taek LIM
;
Jae Uk SHIM
;
Chong Taik PARK
;
Ki Heon LEE
Author Information
1. Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Sungkyunkwan University School of Medicine, Seoul, Korea. 1103khl@hanmail.net
- Publication Type:Original Article
- Keywords:
Sentinel Lymph Node Biopsy;
Uterine Cervical Neoplasms;
iso-sulfan blue;
Conization
- MeSH:
Uterine Cervical Neoplasms/*pathology;
*Sentinel Lymph Node Biopsy;
Neoplasm Staging;
Middle Aged;
Humans;
Female;
Aged;
Adult
- From:Journal of Korean Medical Science
2007;22(1):105-109
- CountryRepublic of Korea
- Language:English
-
Abstract:
The purpose of this study was to determine the feasibility of identifying the sentinel lymph nodes (SNs) as well as to evaluate factors that might influence the SN detection rate in patients with cervical cancer of the uterus. Eighty nine patients underwent intracervical injection of 1% isosulfan blue dye at the time of planned radical hysterectomy and lymphadenectomy between January 2003 and December 2003. With the visual detection of lymph nodes that stained blue, SNs were identified and removed separately. Then all patients underwent complete pelvic lymph node dissection and/or para-aortic lymph node dissection. SNs were identified in 51 of 89 (57.3%) patients. The most common site for SN detection was the external iliac area. Metastatic nodes were detected in 21 of 89 (23.5%) patients. One false negative SN was obtained. Successful SN detection was more likely in patients younger than 50 yr (p=0.02) and with a history of preoperative conization (p=0.05). However, stage, histological type, surgical procedure and neoadjuvant chemotherapy showed no significant difference for SN detection rate. Therefore, the identification of SNs with isosulfan blue dye is feasible and safe. The SN detection rate was high in patients younger than 50 yr or with a history of preoperative conization.
